Costs linked to last year’s acquisition of French rival Forte Pharma have triggered a 24% drop in profits at Spanish functional-foods firm Natraceutical.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more


The company posted nine-month net profit of EUR4.4m (US$6.3m), down 23.6% on the year.


However, the Valencia-based firm said gross operating profit soared 47% to EUR15m. Sales were up 77% to EUR120.8m.


Natraceutical, which makes functional ingredients for the dietary, beauty and health sector, said the acquisition of Forte added EUR82m of debt to its balance sheet.


However, the French firm added EUR49m to sales and EUR8m to Ebitda in the nine-month period and Natraceutical said the unit’s outlook is very positive.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Natraceutical said it will invest “strongly” to expand Forte across Europe and expand its slimming and nutritional supplement products.

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now